BR9909440A - Derivados de indol - Google Patents

Derivados de indol

Info

Publication number
BR9909440A
BR9909440A BR9909440-1A BR9909440A BR9909440A BR 9909440 A BR9909440 A BR 9909440A BR 9909440 A BR9909440 A BR 9909440A BR 9909440 A BR9909440 A BR 9909440A
Authority
BR
Brazil
Prior art keywords
group
aryl
lower alkyl
alkyl group
alkenyl
Prior art date
Application number
BR9909440-1A
Other languages
English (en)
Inventor
Yamasaki Noritsugu
Imoto Takafumi
Teruo Oku
Kayakiri Hiroshi
Onomura Osamu
Hiramura Takahiro
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR9909440A publication Critical patent/BR9909440A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE INDOL"<D>. é fornecido um novo derivado de indol ou um sal do mesmo, que é representado pela fórmula: em que R~ 1~ representa um grupo aril alquila inferior, o referido grupo arila podendo ser substituído com um ou mais grupos selecionados do grupo que consiste em um átomo de halogênio, um grupo arila, um grupo heterocíclico, um grupo aril alquila inferior, um grupo aril alquenila inferior, um grupo halo - alquila inferior, um grupo cicloalquila inferior - alcóxi inferior, um grupo cicloalcóxi inferior - alquila inferior, um grupo aril alquinila inferior, um grupo arilóxi alquila inferior, um grupo aril alcóxi inferior, um grupo alquiltio inferior, um grupo alcóxi inferior, e um grupo alquenila; e R~ 2~ representa um grupo alquila inferior, um grupo alquenila inferior, um grupo arila, ou um grupo heterocíclico, cada um dos quais pode ser substituído com um átomo de hidrogênio, um grupo alquila inferior, um grupo alquenila inferior, ou um grupo arila. O composto da presente invenção possui atividade depressora de açúcar no sangue e atividade inibidora de PDE~ 5~, e é útil em medicina
BR9909440-1A 1998-04-06 1999-04-05 Derivados de indol BR9909440A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9362598 1998-04-06
PCT/JP1999/001798 WO1999051574A1 (en) 1998-04-06 1999-04-05 Indole derivatives

Publications (1)

Publication Number Publication Date
BR9909440A true BR9909440A (pt) 2000-12-26

Family

ID=14087520

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909440-1A BR9909440A (pt) 1998-04-06 1999-04-05 Derivados de indol

Country Status (7)

Country Link
US (1) US20050171185A1 (pt)
EP (1) EP1070705A4 (pt)
KR (1) KR20010052235A (pt)
CN (1) CN1150167C (pt)
BR (1) BR9909440A (pt)
CA (1) CA2327397A1 (pt)
WO (1) WO1999051574A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000028991A1 (en) * 1998-11-13 2000-05-25 Fujisawa Pharmaceutical Co., Ltd. Remedies for polycystic ovary syndrome
AU2001276607A1 (en) * 2000-08-11 2002-02-25 Pfizer Inc. Treatment of the insulin resistance syndrome with selective CGMP PDE5 inhibitors
US6638965B2 (en) 2000-11-01 2003-10-28 Boehringer Ingelheim Pharma Kg Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
MXPA03006936A (es) * 2001-02-02 2003-11-18 Pfizer Tratamiento de diabetes mellitus.
TWI325317B (en) * 2001-09-05 2010-06-01 Eisai R&D Man Co Ltd Appetite-stimulating agents and remedies for anorexia
US20050197376A1 (en) * 2004-03-02 2005-09-08 Fujisawa Pharmaceutical Co. Ltd. Concomitant drugs
TWI735416B (zh) 2014-10-06 2021-08-11 美商維泰克斯製藥公司 囊腫纖維化症跨膜傳導調節蛋白之調節劑
ES2946970T3 (es) 2016-03-31 2023-07-28 Vertex Pharma Regulador de conductancia transmembrana de moduladores de fibrosis quística
SI3519401T1 (sl) 2016-09-30 2022-01-31 Vertex Pharmaceuticals Incorporated Modulator regulatorja transmembranske prevodnosti pri cistični fibrozi, farmacevtski sestavki, postopki zdravljenja in proces za izdelavo modulatorja
CN110267948B (zh) 2016-12-09 2023-12-08 弗特克斯药品有限公司 囊性纤维化跨膜传导调控剂的调节剂、药物组合物、治疗方法和制备所述调节剂的方法
AU2018279646B2 (en) 2017-06-08 2023-04-06 Vertex Pharmaceuticals Incorporated Methods of treatment for cystic fibrosis
MA49631A (fr) 2017-07-17 2020-05-27 Vertex Pharma Méthodes de traitement de la fibrose kystique
TWI799435B (zh) 2017-08-02 2023-04-21 美商維泰克斯製藥公司 製備化合物之製程
US10654829B2 (en) 2017-10-19 2020-05-19 Vertex Pharmaceuticals Incorporated Crystalline forms and compositions of CFTR modulators
KR102716244B1 (ko) 2017-12-08 2024-10-14 버텍스 파마슈티칼스 인코포레이티드 낭포성 섬유증 막횡단 전도 조절자의 조정제의 제조 방법
TWI810243B (zh) 2018-02-05 2023-08-01 美商維泰克斯製藥公司 用於治療囊腫纖化症之醫藥組合物
EP3774825A1 (en) 2018-04-13 2021-02-17 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
US11681922B2 (en) * 2019-11-26 2023-06-20 Numenta, Inc. Performing inference and training using sparse neural network

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916774D0 (en) * 1989-07-21 1989-09-06 Bayer Ag New indole derivatives,a process for their preparation and their use in medicaments
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
WO1997024334A1 (en) * 1995-12-28 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
AU4400597A (en) * 1996-10-08 1998-05-05 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
AU745081B2 (en) * 1997-06-27 2002-03-14 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
TW453999B (en) * 1997-06-27 2001-09-11 Fujisawa Pharmaceutical Co Benzimidazole derivatives
EP1000932B9 (en) * 1997-06-27 2005-12-28 Fujisawa Pharmaceutical Co., Ltd. Aromatic ring derivatives
US6046199A (en) * 1998-01-14 2000-04-04 Cell Pathways, Inc. Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives

Also Published As

Publication number Publication date
US20050171185A1 (en) 2005-08-04
CN1150167C (zh) 2004-05-19
WO1999051574A1 (en) 1999-10-14
HK1037619A1 (en) 2002-02-15
KR20010052235A (ko) 2001-06-25
EP1070705A4 (en) 2002-04-17
EP1070705A1 (en) 2001-01-24
CA2327397A1 (en) 1999-10-14
CN1303371A (zh) 2001-07-11

Similar Documents

Publication Publication Date Title
BR9909440A (pt) Derivados de indol
BR9909146A (pt) Derivados de indol apresentando uma atividade antiviral
ES2063830T3 (es) Agentes antitumorales.
BR9811273A (pt) Derivados de benzimidazol
BR9913097B1 (pt) Derivado heterocíclico de carboxamida contendo nitrogênio ou um sal do mesmo
BR122017028096B8 (pt) composto, composição farmacêutica, e, uso do composto
BR0011274A (pt) Derivados tipo indol como inibidores de p38 quinase
GEP20032913B (en) Thienylazolylalcoxyethanamines, Their Preparation and Their Application as Medicaments
CO4910135A1 (es) Derivados cetolidos 6-0 sustituidos de la eritromicina que tienen actividad bacteriana
TR200100659T2 (tr) 5-HT2C agonistleri olarak piroloindoller, piridoindoller ve azepinoindoller.
BR0214224A (pt) Derivado de 4,4-diflúor-1,2,3,4-tetrahidro-5h-1-benzazepina ou sal do mesmo
BRPI0408591A (pt) derivados de 6,7,8,9-tetrahidropirimido[1,2-a] pirimidin-4-ona 8-substituìda
DK0599890T3 (da) Geneserinderivater som cholinesteraseinhibitorer
BRPI0414738A (pt) derivados de ácido acético substituìdos
DE10199016I2 (de) Indol derivate zur Behandlung von Migraene
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
KR910009672A (ko) 피리다진 유도체, 이의 제조방법 및 이것을 함유하는 약학 조성물
BR9902651A (pt) Derivados de diaza-espiro[3,5]nonano
BR0011534A (pt) Alquilaminas aril substituìdas capazes de ativação de receptores colinérgicos nicotìnicos
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ES2172294T3 (es) Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CO4930268A1 (es) BENZO[e]ISOINDOLES Y BENZO[h]ISOQUINOLINAS TRICICLICOS
BR0315386A (pt) Abridor de canal de k ativado por cálcio de condutância grande
NO20012443D0 (no) Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel
BR0014640A (pt) Composto de amida e composição farmacêutica compreendendo dito composto de amida

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP)

Free format text: TRANSFERIDO POR FUSAO DE: FUJISAWA PHARMACEUTICAL CO., LTD.

B25D Requested change of name of applicant approved

Owner name: ASTELLAS PHARMA INC. (JP)

Free format text: ALTERADO DE: YAMANOUCHI PHARMACEUTICAL CO., LTD.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1945 DE 15 - 04 - 2008.